EUROIMMUN launches quantitative ELISA to measure SARS-CoV-2 antibodies against viral S1 protein
Underscores importance of serological testing using the S1 subunit for worldwide seroprevalence and vaccine development
Underscores importance of serological testing using the S1 subunit for worldwide seroprevalence and vaccine development
Discover the importance of high-throughput and robust methodologies for finding ‘needle-in-the-haystack’ therapeutic antibodies
Study enrolled 43,538 participants, with 42% having diverse backgrounds, and no serious safety concerns have been observed; Safety and additional efficacy data continue to be collected
This project aims to produce an antiviral and antifouling coating which can be used on PPE to protect staff working in healthcare settings
From ultrafiltration and extraction to glycosylation and imaging, discover the latest technologies, top tips, and best practices for protein biology research
Company’s latest test enables differential diagnosis between COVID-19, flu and RSV infection
New sample collection kit enables convenient and safe collection, transportation and handling of pathogenic samples including COVID-19 and influenza
Study by University of Manchester reassures patients that it is safe to take blood pressure medication during the pandemic
Which new products made the most difference to your lab work this year?
Gene and cell therapy expert Dr. Gerhard Bauer explores the powerful therapies that use a patient's own immune cells to treat cancer
New kit aims to provide highly sensitive and efficient approach for studying mitophagy impairment in conditions such as Parkinson’s and Alzheimer’s
The study leverages the Tapestri Platform to illustrate the single-cell atlas of acute myeloid leukemia (AML) with multi-omics, describing the clonality underlying therapeutic resistance
Proven, scalable platform aims to increase dose yields and reduces process development time for cell and gene therapies
Veklury is first FDA-approved treatment for COVID-19 in the US, and aims to shorten time to recovery by five days
Roche and Atea partner to jointly develop AT-527, an orally administered direct-acting antiviral (DAA) currently in Phase 2 clinical trials
The hypercube algorithm aims to enable regular, cost-effective screening in multiple contexts
Learn the importance of low LoD tests and discover the most sensitive kits available, as determined by the FDA’s SARS-CoV-2 Reference Panel
Find out how Zymo Research’s state-of-the-art tools are helping laboratories and government agencies facilitate large-scale COVID-19 testing in the United States